# Expanded Access for Treatment Use of PLX-PAD in Critical Limb Ischemia (CLI)

> **NCT03746899** · — · AVAILABLE · sponsor: **WideTrial, Inc.**

## Conditions studied

- Critical Limb Ischemia (CLI)

## Interventions

- **BIOLOGICAL:** PLX-PAD

## Key facts

- **NCT ID:** NCT03746899
- **Lead sponsor:** WideTrial, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2019-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03746899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03746899, "Expanded Access for Treatment Use of PLX-PAD in Critical Limb Ischemia (CLI)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03746899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*